DEV of an ultra-sensitive and cost-effective home-based disposable molecular platform for sars-COV-2 testing arete biosciences AOI #4.1 covid-19
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00035
- Awardee
-
Arete Biosciences, Inc. UEI LTRACP68B951
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $745,000
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $745,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60654, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $745,000 |
About this award
Arete Biosciences, LLC was awarded a $745,000 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an ultra-sensitive and cost-effective home-based disposable molecular platform for SARS-CoV-2 testing. The contract is being performed in Chicago, Illinois over a period of one year from June 2022 through August 2023. The award is responsive to Special Instructions 019 under the HHS ASPR Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury through Area of Interest 12. Arete Biosciences will pursue safety review of candidates through Phase I and share resulting data and commercialization plans with the agency.
Quick answers
Who was awarded contract 75A50122C00035?
75A50122C00035 was awarded to Arete Biosciences, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 21, 2022.
How much is contract 75A50122C00035 worth?
The government has obligated $745,000 on 75A50122C00035.
Was contract 75A50122C00035 competed?
The extent of competition for 75A50122C00035 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award